In the latest trading session, 1.01 million Yield10 Bioscience Inc (NASDAQ:YTEN) shares changed hands as the company’s beta touched 1.75. With the company’s most recent per share price at $0.24 changed hands at -$0.03 or -11.07% at last look, the market valuation stands at $2.88M. YTEN’s current price is a discount, trading about -1645.83% off its 52-week high of $4.19. The share price had its 52-week low at $0.21, which suggests the last value was 12.5% up since then. When we look at Yield10 Bioscience Inc’s average trading volume, we note the 10-day average is 0.21 million shares, with the 3-month average coming to 223.87K.

Analysts gave the Yield10 Bioscience Inc (YTEN) stock a consensus recommendation rating of an Overweight, calculated at a mean rating of 1.67. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended YTEN as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Yield10 Bioscience Inc’s EPS for the current quarter is expected to be -$0.28.

Yield10 Bioscience Inc (NASDAQ:YTEN) trade information

Instantly YTEN was in red as seen in intraday trades today. With action -21.54%, the performance over the past five days has been red. The drop to weekly highs of 0.3170 on Friday, 11/17/23 subtracted -11.07% to the stock’s daily price. The company’s shares are showing year-to-date downside of -85.62%, with the 5-day performance at -21.54% in the red. However, in the 30-day time frame, Yield10 Bioscience Inc (NASDAQ:YTEN) is -27.24% down. Looking at the short shares, we see there were 0.13 million shares sold at short interest cover period of 0.73 days.

The consensus price target for the stock as assigned by Wall Street analysts is $3.50, meaning bulls need an upside of 93.14% from its recent market value. According to analyst projections, YTEN’s forecast low is $3.00 with $4.00 as the target high. To hit the forecast high, the stock’s price needs a -1566.67% plunge from its current level, while the stock would need to soar -1150.0% for it to hit the projected low.

Yield10 Bioscience Inc (YTEN) estimates and forecasts

Data shows that the Yield10 Bioscience Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -91.63% over the past 6 months, a 26.09% in annual growth rate that is considerably higher than the industry average of 22.20%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Yield10 Bioscience Inc will rise 58.20%, while the growth in revenue is estimated to hit 59.20% for the next quarter. Year-over-year growth is forecast to reach -80.00% down from the last financial year.

Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of $30k. The company’s revenue for the corresponding quarters a year ago was $87k and $60k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -65.50%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 53.83%. The 2023 estimates are for Yield10 Bioscience Inc earnings to increase by 27.17%, but the outlook for the next 5-year period is at 0.00% per year.

YTEN Dividends

Yield10 Bioscience Inc is expected to release its next quarterly earnings report on November 14.

Yield10 Bioscience Inc (NASDAQ:YTEN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 18.12% of Yield10 Bioscience Inc shares while 8.06% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 9.84%. There are 8.06% institutions holding the Yield10 Bioscience Inc stock share, with Cannell (Peter B.) & Company Inc the top institutional holder. As of Sep 29, 2023, the company held 2.16% of the shares, roughly 0.26 million YTEN shares worth $63518.0.

Geode Capital Management, LLC holds the second largest percentage of outstanding shares, with 0.52% or 62497.0 shares worth $15336.0 as of Sep 29, 2023.

Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 65737.0 shares estimated at $16131.0 under it, the former controlled 0.55% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.34% of the shares, roughly 40451.0 shares worth around $9926.0.